Immuron Limited


Immuron Limited (ASX: IMC) is an Australian microbiome biopharmaceutical company which is involved in marketing and selling of Travelan® which is used for the prevention of Travelers’ Diarrhoea. The company is currently headed by Dr. Gary S. Jacob who is the CEO of the company. The headquarter of the company is located in Carlton, Victoria, Australia.

Contact Information

company address Level 3, 62 Lygon Street, CARLTON, VIC, AUSTRALIA, 3053

company phone+61 (0)3 9824 5254

company website

Similar Companies

Load More
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK